Drug intelligence / Profile preview

Si-Shun-Tang

Development stage: Unknown
Administration: Oral

Overview

Si-Shun-Tang (四顺汤) is a Traditional Chinese Medicine (TCM) formula traditionally used to treat conditions such as lung carbuncle (肺痈吐脓), vexation and heat in the five centers (五心烦热), and oppressive cough (壅闷咳嗽). It is composed of four main herbs: Fritillaria (贝母), Platycodon (桔梗), Aster (紫菀), and Licorice (甘草). It is prepared by coarsely crushing and sifting the four herbs, then decocting them in water.

Other names: 四顺散

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)MAPK14 (p38 mitogen-activated protein kinase alpha)RELA (Nuclear Factor Kappa B Subunit p65)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on Si-Shun-Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Si-Shun-Tang.